NEW YORK, Aug. 2 /PRNewswire/ -- NeuroTrax Corporation and Clalit Health Services Ltd. (Tel Aviv, http://www.clalit.co.il) have announced today that Clalit has adopted the NeuroTrax Mindstreams(R) products as the standard cognitive assessment tools for use with its geriatric population. Clalit, which operates 14 hospitals and 1,250 outpatient clinics and employs 9,000 physicians, is the largest managed care organization in Israel and insures 3.8 million people, including 80% of the country's seniors. Clalit started to deploy Mindstreams(R) in its outpatient clinics throughout Israel in October 2004. The primary application is early detection of dementia and tracking the patient's cognitive function in different stages of dementia; later applications may include mental health and learning disorders. According to Clalit's Executive Director of Medical Services, Dr. Nicky Lieberman, "One of our most difficult challenges is providing uniform care throughout our healthcare system -- especially for the growing older adult population. We rely upon NeuroTrax to provide objective and standardized cognitive measurement upon which to base state-of-the-art care throughout our geriatric care system. I am impressed with the practical nature of the Mindstreams products and the high scientific standards of NeuroTrax."
NeuroTrax Corporation was founded in 2000 with the goal of improving the practice of medicine by offering practical low-cost products and services for neurological and psychiatric disease management. "Accurate and standardized office-based measurement of cognitive function has become critical for neurological and psychiatric disease management. NeuroTrax offers user-friendly technologically-advanced solutions for large organizations, such as Clalit, that depend upon reliable approaches to outcomes measurement," according to Ely Simon, M.D., a board certified neurologist and creator of Mindstreams(R). Mindstreams(R) is used in major healthcare systems and universities, as well as in private medical offices.
For more information, call toll-free 888-208-8160 or visit http://www.neurotrax.com.
SOURCE NeuroTrax Corporation; Clalit Health Services Ltd.
CONTACT: Ely Simon, M.D. of NeuroTrax Corporation, 1-888-208-8160, ely.simon@neurotrax.com
© PR Newswire
Only GlobeinvestorGOLD combines the strength of powerful investing tools with the insight of The Globe and Mail.
Discover a wealth of investment information and and exclusive features.
